copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier . . . Pfizer Inc (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands The Boards of Directors of both companies have unanimously approved the transaction under which Pfizer will contribute its consumer healthcare business to GlaxoSmithKline’s existing consumer healthcare
Update: Proposed demerger of the Consumer Healthcare business . . . - GSK Prior to the Demerger, GlaxoSmithKline Consumer Healthcare Holdings (No 2) Limited (“JVCo”), the current holding company of the Consumer Healthcare business, will pay dividends to GSK and Pfizer, which are expected to result in GSK receiving cash proceeds of more than £7 billion at separation (the “Pre-Demerger Dividends”)
Consumer Healthcare Demerger - GSK The Consumer Healthcare business was a joint venture between GSK and Pfizer Inc (“Pfizer”), with GSK holding a majority controlling interest of 68% and Pfizer holding 32% A General Meeting to approve two resolutions covering: the Demerger and the GSK Share Consolidation; and the Related Party Transactions, was held on Wednesday 6 July 2022
GSK announces independent Consumer Healthcare company is to be called . . . Mississauga, ON - GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon Haleon (pronounced "Hay-Lee-On") is inspired by the merging of the words 'Hale', which is an old English word that means 'in good health' and Leon, which is
New consumer healthcare company to be called Haleon Metrics GlaxoSmithKline plc (GSK) announced on 22 February that a new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon Haleon
Haleon CMD to demerger archive - GSK Committed to delivering attractive sustainable growth, maximizing shareholder value Tobias Hestler, Chief Financial Officer Designate, Haleon 15:50-15:55 Bringing it all together Brian McNamara, Chief Executive Officer Designate, Haleon Download agenda - PDF - 66kb We expect to demerge our world leading consumer healthcare business
GlaxoSmithKline and Pfizer agree £10bn healthcare merger GlaxoSmithKline (GSK) is to merge its consumer healthcare unit with that of rival Pfizer, to create a new market leader with almost £10bn in annual sales The UK pharmaceutical firm - behind many